The Incidence, Risk Factors, and Effects of Constipation in Critical Patients
NCT ID: NCT05683743
Last Updated: 2023-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
116 participants
OBSERVATIONAL
2018-12-01
2019-07-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevention of Constipation in Cancer Patients
NCT07007468
"The Effect of Abdominal Massage on Gastrointestinal Functions in Mechanically Ventilated Patients Receiving Enteral Nutrition in Intensive Care"
NCT06631001
Constipation Bundle/Protocol and the Effect of Adherence in the Incidence of Constipation in Critically Ill Patients
NCT04462211
Effect of Abdominal Massage on Constipation After Cardiac Surgery
NCT06596421
Fiber-Enriched Enteral Nutrition and Opioid-Induced Constipation in the ICU
NCT07201428
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Constipation is an important issue, especially in intensive care patients, requiring careful discussion since it has negative effects as well as high incidence and excessive risk factors. Furthermore, untreated constipation in these patients delays enteral feeding prolonging the time of weaning from the mechanical ventilator, which consequently increases the duration of stay in the intensive care unit. Additionally, it involves complications such as distention, nausea-vomiting, an increase in bacterial infection rate, high morbidity, and mortality. Therefore, the definitions, risks, and effects of constipation, especially early and late constipation, in critically ill patients should be determined for evidence-based interventions. However, studies on the subject are limited.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not abdominal surgery
* Not stoma
* Not constipation during admission
* Not intraperitoneal infection
* Not had a recent colonoscopy -\> 5 hospitalization days
Exclusion Criteria
* Order for regular laxatives or enemas
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abant Izzet Baysal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Arzu AKMAN YILMAZ
Asst. Prof
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arzu AKMAN YILMAZ, RN, PhD.
Role: PRINCIPAL_INVESTIGATOR
Bolu Izzet Baysal University
Seyma OZDEMIR, RN,MSN.
Role: PRINCIPAL_INVESTIGATOR
Pursaklar State Hospital
Esra OZDEMIR, MD.
Role: PRINCIPAL_INVESTIGATOR
Bolu Izzet Baysal State Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bolu Izzet Baysal State Hospital, Anesthesia Intensive Care Unit
Bolu, Merkez, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BAIBU-HEM-AAY-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.